Anti–PD-1 therapy (pembrolizumab, nivolumab) supports neoadjuvant and adjuvant management of higher-risk melanoma, offering durable remissions with less systemic toxicity than traditional chemotherapy ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Netherlands data reveal how lentigo maligna is treated in the Netherlands, with notable upstaging and recurrence rates. Read more.

Wide local excision with a 5-mm margin for smaller melanomas in situ (MISs) may be appropriate for sites at low risk of recurrence, Australian researchers suggested, despite recent guidelines ...

Please provide your email address to receive an email when new articles are posted on . Patients with upstaged tumors saw an overall mortality rate of 36% vs. 19.5% in their non-upstaged counterparts.

Q: My sister-in-law is 82 years old and was recently diagnosed with melanoma. She has an appointment for treatment in a couple of weeks. I thought this was a serious and deadly disease. Can a patient ...

This patient had lentigo maligna melanoma, a cancerous lesion that most commonly arises as a tan or brown macule on sun-damaged surfaces of the skin. 3 The lesion acquires a darker, asymmetrical ...

Samer Wahood, AB, shares that his research reveals a significant link between July erythemal UV radiation exposure and increased risks of melanoma in situ and invasive melanoma. In this interview, ...

Dear Doctors: My sister-in-law is 82 years old and was recently diagnosed with melanoma. She has an appointment for treatment in a couple of weeks. I thought this was a serious and deadly disease. Can ...